Company News
-
Sertio Oy Chairman & CEO Mikko Soikkeli Visits Macro & Micro-Test to Strengthen IVDR Collaboration and Present New Certificates
Sertio Oy Chairman & CEO Mikko Soikkeli Visits Macro & Micro-Test to Strengthen IVDR Collaboration and Present New Certificates Suzhou, China – Mikko Soikkeli, Chairman and CEO of Sertio Oy, recently visited Macro & Micro-Test. During the visit, the two parties held in-depth discussio...Read more -
Beyond Infection: Toward a Comprehensive Understanding of Women’s Vaginal Health
Vaginal health is far more than the presence or absence of pathogens. The vaginal environment is a dynamic ecosystem influenced by the interaction between microbial communities, opportunistic microorganisms, host factors, and antimicrobial resistance mechanisms. Changes within this ecosystem may ...Read more -
Unlock Precision Treatment for NSCLC with Guideline-Recommended EGFR Mutation Testing
Lung cancer remains one of the world’s leading causes of cancer-related mortality, with non-small cell lung cancer (NSCLC) accounting for more than 80% of all lung cancer cases. In 2020 alone, more than 2.2 million new lung cancer cases were diagnosed worldwide As precision oncology contin...Read more -
Outbreak of Group C Rotavirus in a Primary School in Luzhou, China, and Macro & Micro-Test’s Whole-Genome Sequencing Technology Enables Precise Source Tracing
Recently, China CDC Weekly published an important research article describing the epidemiological and etiological investigation of an acute gastroenteritis outbreak caused by Group C rotavirus (RVC) at a primary school in Luzhou, Sichuan Province, in October 2025. Notably, Macro & Micro-Test’...Read more -
World Hepatitis Day 2026: Breaking Down Barriers with Precision Testing to Accelerate Hepatitis Elimination
On July 28, 2026, the world observes World Hepatitis Day, a global initiative dedicated to raising awareness and accelerating action against viral hepatitis. This year’s theme, “Hepatitis: Let’s break it down,” calls for removing the barriers that limit access to hepatitis prevention, testing, tr...Read more -
A Landmark Lancet Infectious Diseases Study Reveals the Global Evolution of HIV-1 (1990–2024)
Global and regional molecular epidemiology of HIV-1 during 1990-2024：systematic review, global survey, and analysis of prevalence Introduction A recent study published in The Lancet Infectious Diseases (2026) provides the most comprehensive global analysis of HIV-1 molecular epidemiology to dat...Read more -
The Growing AMR Crisis: Why Rapid Detection Is Key to Fighting Drug-Resistant Infections
Antimicrobial resistance (AMR) has become one of the greatest threats to global public health. A landmark study published in The Lancet estimated that 1.27 million deaths in 2019 were directly attributable to bacterial antimicrobial resistance (AMR), while nearly 5 million deaths were associated ...Read more -
The Hygienic FIT Test: Advancing Early Detection of Colorectal Cancer
Why Fecal Occult Blood Matters Colorectal cancer is one of the leading causes of cancer-related morbidity and mortality worldwide. Most colorectal cancers develop gradually from precancerous polyps over several years, creating a valuable window for early detection and in...Read more -
GBS Awareness Week 2026 From Awareness to Action: The Future of GBS Care
Turning Awareness into Action Every year, GBS Awareness Week from July 8-12 brings together healthcare professionals, advocacy organizations, and communities around the world with a shared goal: increasing awareness of Group B Streptococcus (GBS) and its impact on maternal and newborn health. Ove...Read more -
IVDR Certified Carbapenemase Detection Solution Rapid Molecular Detection of KPC, NDM, OXA-48, OXA-23, VIM and IMP
The global spread of carbapenem-resistant bacteria continues to threaten effective antimicrobial therapy, making rapid identification of carbapenemase-producing organisms more important than ever. To support timely clinical decision-making and antimicrobial resistance (AMR) surveillance, Macro &a...Read more -
Macro & Micro-Test Technology Featured in Nepal’s First National HPV DNA Screening Program Presented at AMP Europe 2026
Macro & Micro-Test is proud that its HPV molecular diagnostic technology was utilized in Nepal’s first nationwide HPV DNA-based cervical cancer screening program. The study results were selected for Oral Presentation at the AMP Europe 2026 Congress and published in the Journal of Molecu...Read more -
Macro & Micro-Test Once Again Collaborates with National Research Teams to Uncover Cross-Species Transmission Characteristics of Brucella on the Qinghai–Tibet Plateau
Following its previous whole-genome tracing study of Brucella abortus in cattle from Zhejiang Province , the bioinformatics team at Macro & Micro-Test has once again contributed to a collaborative genomic investigation of Brucella. The study, entitled “Identification and Genome Phylogenetic ...Read more